However, despite a strong trend towards an impaired prognosis in patients with low TWEAK serum levels (below 808.3 ng/mL), this ideal cut-off value was still unable to significantly identify a subgroup of patients with an impaired overall survival ( Figure 3 D).
← all excerpts
Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.
1
—
—